In human lung cancer, the main Wnt ligands are Wnt1, Wnt2, Wnt5a, and Wnt7a, and an increase in Wnt proteins, Wnt1 or Wnt5a alone, is significantly related to poor prognosis in NSCLC (84). Here, WNT5A is linked to lung carcinoma.